Department of Anesthesiology and Reanimation, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Department of Anesthesiology and Reanimation, Inonu University Faculty of Medicine, Malatya, Turkey.
J Clin Anesth. 2018 Nov;50:5-11. doi: 10.1016/j.jclinane.2018.06.030. Epub 2018 Jun 20.
Multimodal analgesic strategies are recommended to decrease opioid requirements and opioid-induced respiratory complications in patients undergoing laparoscopic bariatric surgery. Recent studies have demonstrated that intravenous ibuprofen decreases opioid consumption compared with placebo. The primary aim of this study was to compare the effect of intravenous ibuprofen and intravenous acetaminophen on opioid consumption. We also aimed to compare postoperative pain levels and side effects of the drugs.
Randomized, double-blinded study.
University hospital.
Eighty patients, aged 18-65 years, (ASA physical status II-III) undergoing laparoscopic sleeve gastrectomy or laparoscopic Roux-en-Y gastric bypass surgery were included in this study.
Patients were randomized to receive 800 mg ibuprofen or 1 g acetaminophen intravenously every 6 h for the first 24 h following surgery; in addition, patient-controlled analgesia with morphine was administered.
Postoperative morphine consumption in the first 24 h, visual analog scale (VAS) pain scores at rest and with movement, and opioid related side effects were assessed. In addition, time to passage of flatus, surgical complications, lengths of intensive care unit and hospital stay, and laboratory parameters were recorded.
The mean morphine consumption was 23.94 ± 13.89 mg in iv ibuprofen group and 30.23 ± 13.76 mg in the acetaminophen group [mean difference: -6.28 (95% CI, -12.70, 0.12); P = 0.055]. The use of intravenous ibuprofen was associated with reduction in pain at rest (AUC, 1- to 24-h, P < 0.001 and 12- to 24-h, P = 0.021) and pain with movement (AUC, 1-24, 6-24, and 12-24 h, P < 0.001). Intravenous ibuprofen was well tolerated with no serious side effects except dizziness.
Intravenous ibuprofen did not significantly reduce opioid consumption compared to intravenous acetaminophen; however, it reduced the severity of pain. Intravenous ibuprofen may be a good alternative to intravenous acetaminophen as part of a multimodal postoperative analgesia in patients undergoing bariatric surgery.
腹腔镜减重手术中,推荐采用多模式镇痛策略以减少阿片类药物的需求和阿片类药物引起的呼吸并发症。最近的研究表明,与安慰剂相比,静脉注射布洛芬可减少阿片类药物的消耗。本研究的主要目的是比较静脉注射布洛芬和静脉注射对乙酰氨基酚对阿片类药物消耗的影响。我们还旨在比较两种药物的术后疼痛水平和副作用。
随机、双盲研究。
大学医院。
80 例年龄在 18-65 岁之间(ASA 身体状况 II-III)的患者,接受腹腔镜袖状胃切除术或腹腔镜 Roux-en-Y 胃旁路手术,纳入本研究。
患者随机接受 800mg 布洛芬或 1g 对乙酰氨基酚静脉注射,每 6 小时一次,持续 24 小时;此外,给予吗啡患者自控镇痛。
术后 24 小时内吗啡消耗量、静息和运动时视觉模拟量表(VAS)疼痛评分以及与阿片类药物相关的副作用。此外,记录肛门排气时间、手术并发症、重症监护病房和住院时间以及实验室参数。
静脉注射布洛芬组的平均吗啡消耗量为 23.94±13.89mg,对乙酰氨基酚组为 30.23±13.76mg[平均差异:-6.28(95%CI,-12.70,0.12);P=0.055]。静脉注射布洛芬与静息时疼痛减轻相关(AUC,1 至 24 小时,P<0.001 和 12 至 24 小时,P=0.021)和运动时疼痛减轻(AUC,1-24、6-24 和 12-24 小时,P<0.001)。静脉注射布洛芬除头晕外耐受性良好,无严重副作用。
与静脉注射对乙酰氨基酚相比,静脉注射布洛芬并未显著减少阿片类药物的消耗;然而,它降低了疼痛的严重程度。在接受减重手术的患者中,静脉注射布洛芬可能是静脉注射对乙酰氨基酚作为多模式术后镇痛的一种良好替代。